Form 6-K Satellos Bioscience Inc. For: Aug 14

August 14, 2026 4:36 PM EDT

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-
16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of August 2026

 

Commission File Number: 001-43107

 

SATELLOS BIOSCIENCE INC.
(Translation of registrant's name into English)

 

15 Allstate Parkway, Suite 600, Markham,
Ontario, Canada L3R 5B4

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ¨ Form 40-F x

 

 

 

 

 

 

INCORPORATION BY REFERENCE

 

This Report on Form 6-K, including Exhibit 99.1, is incorporated by reference into the Registrant’s Registration Statement on Form F-10 (File No. 333-298223) and the Registrant’s Registration Statement on Form S-8 (File No. 333-294666), to be a part thereof from the date on which this Report on Form 6-K is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

 

 

 

 

DOCUMENTS INCLUDED AS PART OF THIS REPORT

 

Exhibit  
   
99.1 Sales Agreement, dated August 14, 2026, by and between Satellos Bioscience Inc. and Leerink Partners LLC.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  SATELLOS BIOSCIENCE INC.
     
Date: August 14, 2026 By: /s/ Elizabeth Williams, CPA, CA
    Name: Elizabeth Williams, CPA, CA
    Title: Chief Financial Officer

 

 

ATTACHMENTS / EXHIBITS

EXHIBIT 99.1



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings